Novel medical therapy against viral-induced lung damage. Development of OGG1 inhibitors against lung inflammation and pulmonary fibrosis induced by viral infection
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.